ANTICHOLINESTERASE ACTIVITY OF PLANT EXTRACTS OF SMILAX ZEYLANICA AND SMILAX CHINA
HTML Full TextANTICHOLINESTERASE ACTIVITY OF PLANT EXTRACTS OF SMILAX ZEYLANICA AND SMILAX CHINA
A. Yokeshwaran *, V. V. Venkatachalam, B. Sabarisenthil and V. K. Kalaichelvan
Department of Pharmacy, FEAT, Annamalai University, Annamalai Nagar, Chidambaram - 608002, Tamil Nadu, India.
ABSTRACT: Alzheimer’s disease is the most common neurodegenerative disease, which initially causes oxidative stresses and leads to neuronal death. It characterized by notable memory loss, cognitive impairment, and personality disorders accompanied by diffuse structural abnormalities in the brain of the aged population. The present work focused on anticholinesterase inhibiting activity Smilax zeylanica and Smilax china against neurodegenerative disorder such as Alzheimer’s diseases on animal model respectively, as proof of preliminary anticholinesterase profile. In this paper, we studied various extracts prepared from roots of Smilax zeylanica and Smilax china for their AChE -inhibitory activity using animals. The ethanolic and various extracts from the plant roots of smilax zeylanica and smilax china were screened for their acetylcholinesterase inhibitory activity by using animals and Ellman’s method. These extracts of smilax china and smilax zeylanica exhibited inhibitory activities were observed (Cortex and Hippocampus) at a concentration of 150 mg/kg, it can be used for further study to treat the neurodegenerative disorders like Alzheimer’s disease (AD).
Keywords: |
Plant extracts, AchE, Wistar rats and Alzheimer's disease
INTRODUCTION: Alzheimer’s disease is the most common neurodegenerative disease, which initially causes oxidative stresses and leads to neuronal death. It characterized by notable memory loss, cognitive impairment, and personality disorders accompanied by diffuse structural abnormalities in the brain of aged population 1. It affects millions of people, and it has become a major medical and social burden globally 2. During the course of the disease, the senile plaques (SPs) of amyloid-beta (A-beta) peptides and the neurofibrillary tangles (NFTs) of the tau protein develop in the specific regions of the brain, leading to the death of neuronal cells 3.
A cholinergic system in the brain, especially the basal forebrain projections to the hippocampus and cortex, is responsible for memory and learning and known to be affected in Alzheimer’s disease 4. Alzheimer’s brain has low levels of acetylcholine, which can arise from the accumulation of A-beta protein fragments, which form hard plaques that can interfere with the ability of acetylcholine to affect synaptic transmission.
Neurofibrillary tangles are primarily composed of paired helical filaments consisting of hyper-phosphorylated tau. Tau pathology typically begins in the allocortex of the medial temporal lobe (entorhinal cortex and hippocampus) before spreading to the associative isocortex. Primary sensory, motor, and visual areas tend to be relatively spared. Neuronal and synapse loss typically parallel tangle formation, and as such the clinical features and severity of AD are better correlated with NFT pathology 5, abnormally folded Aβ and tau have been shown to induce a conformational change in structurally normal peptides, these may be transferred trans-synaptically from one neuron to another 6. Hence, the present work focused on anticholinesterase inhibiting activity S. zeylanica and S. china against neurodegenerative disorders such as Alzheimer’s diseases on animal models, respectively, as proof of preliminary anticholinesterase profile. In this paper, we studied various extracts prepared from the roots of Smilax zeylanica and Smilax china for their AChE-inhibitory activity using animals.
MATERIALS AND METHODS:
Plant Materials:
Collection and Identification of Plant Materials: The roots of Smilax china and Smilax zeylanica were collected from Marthandam, Kanyakumari District, Tamil Nadu, India. Taxonomic identification was made from the Botanical Survey of Medical Plants Unit Siddha, Palayamkottai, Government of India (Authentication Ref no. 01/08/2016). The roots of Smilax china were dried under shade, segregated, pulverized by a mechanical grinder and passed through the no: 40 mesh sieves 7, 8.
Preparation of Extracts: The above-powdered plant materials were consecutively extracted with pet. ether at 40-60 °C by hot continuous percolation method in the Soxhlet apparatus for one day. The marc was dried out and extracted with chloroform, and then marc was extracted with ethyl acetate (76-78 °C) for one day, then this marc was dried out after that it was extracted with ethanol for one day, and then marc was extracted with water. All the three extracts were concentrated by utilizing a rotary evaporator and undergone to freeze-drying using a lyophilizer until the dry powder was acquired. The ethanolic extract gave more yield, and more phytoconstituents were present. So, the ethanolic extract of Smilax china (EESC) was selected for further investigation. The ethanolic extract gave more yield, and more phytoconstituents were present. So, the ethanolic extract of Smilax zeylanica (EESZ) was selected for further investigation 9-12.
General Chemicals and Reagents used for the Present Study and their Source: Unless stated, general chemicals and reagents were purchased from Sigma, Span, Nice, Chemsworth, Wockhardt and Sd. fine chemicals of analytical grade or equivalent.
- 5,5-dithio bis-2-nitro benzoic acid from Sigma Chemicals, USA.
- Acetone and Ethanol (AR) from Nice Chemicals, Kerala, India.
- Acetyl acetone, Acetylthiocholine iodide, Potassium dihydrogen phosphate, Aluminium Chloride, Chloroform (AR), Dipotassium-monohydrogen Phosphate, Dithiobisnitro-benzoic acid (DTNB), Ethyl Acetate (AR), Petroleum ether (AR) and Potassium dichro-mate from Sd. fine chemicals, Mumbai, India.
- Saline Wockhardt Pharmaceuticals, India.
- Ellman's reagent 19.8 mg of 5,5-dithio-bis-2-nitro benzoic acid was dissolved in 100 ml of 1% sodium citrate solution 13, 14.
Acetylcholine Esterase Activity:
Solutions: Phosphate buffer with 0.1 M at pH 8.0.
Substrate: Acetylthiocholine iodide solution 0.075 M prepared as a stock solution and stored in refrigerator 15.
Reagent: 0.01 M Dithiobisnitrobenzoic acid (DTNB) was prepared by dissolving 39.6 mg of 5:5-dithiobis-2-nitrobenzoic acid in 10 ml of 0.1 M phosphate buffer (pH7.0) and 15 mg of sodium bicarbonate. The reagent was made up in buffer of pH 7 and finally adjusted to pH 8, since it was more stable.
Enzyme: 20 ml of 1% gelatin was prepared and bovine erythrocyte cholinesterase was dissolved into it and diluted to a concentration of 5 units per ml by adding 1:200 with water.
Procedure: 3 ml of phosphate buffer (pH 8.0) is mixed with 20.0 μl of a substrate and 100 μl of DTNB and 50 μl of the enzyme. A blank solution was also prepared without enzyme, i.e., blank consists of the buffer, substrate, and DTNB solutions. The readings were recorded after 30 min, in order to complete the hydrolysis reaction. A standard and linear graph were prepared from the absorbances. In pH 8, there is substantial non-enzymatic hydrolysis of the substrate.
Finally, all the animals were sacrificed by giving mild ketamine and followed by cervical dislocation. The brains were isolated and collected and homogenized (about 20 mg of tissue per ml of phosphate buffer (pH 8.0, 0.1 M) in a homogenizer. 0.4 ml of aliquot homogenate was mixed with 2.6 ml of phosphate buffer (pH 8.0; 0.1 M). To that, 100 μl of DTNB reagent was added to the photocell. The absorbance was read at 412 μm, and 20 μl of substrate was also added.
Absorbance was recorded and calculated as follows:
R = 0.000574 × ΔA/ Co
Where, R = rate, in moles substrate hydrolyzed/ min/ g of brain; ΔA = change in absorbance per min, Co = original concentration (mg/ml)
Experimental Animals: 16-19 weeks-old adult male Wistar rats, weighing approximately 150 to 200g and 2-3months adult female albino mice, weighing approximately 20-25 were acclimatized for 7 days at temperature (25 ± 2 °C) and relative humidity (55 ± 1%) in a 12-hour light/dark cycle at room under hygienic condition 16-18. They were given access to water and fed with standard pellet diet ad libitum. The experiments were approved as per the strategy of CPCSEA, New Delhi, India, and approved by the Annamalai University IAEC (Approved number: AU/IAEC/1199/1/18).
Administration of Ethanolic Extract of Roots of Smilax zeylanica and Smilax china (EESZ & EESC): Five animals were used for each step of the study. Animals made to fast prior to dosing (food was withdrawn overnight, and water was withdrawn 3 h before drug administration) following the period of fasting. The animals were weighed, and the extract was administered in a single dose with normal saline, by oral intubation. Food was withheld for further one hour after the administration of a drug. The study obtained from the OECD-424 up and down method and the dose level selected for the study with a dose of 1.75, 5.55. 17.5. 55, 175, 550, 1750 and 2000/kg/p.o/b.wt. If the first animal survived, the second animal received a higher dose. If the first animal died or appeared moribund, the second animal received a lower dose. The time interval between drug treatment groups was concluded by the onset, period, and severity of toxic indications. Extract treatment groups at the next dosage should be postponed until one becomes certain of the survival of the formerly dosed animals. Administration of EESZ and EESZ (doses of 150 mg/kg b.wt and 150 mg/kg b.wt) 19.
Observations: Mice were carefully observed for first 3 h and up to 6 h after dosing & then periodically for 6 h, 12 h, 24 h, and 48 h daily thereafter, for a total of 14 days additional observations 63 were also made when the animals continued to display signs of toxicity observations such as a change in the skin, fur eyes and mucus membranes, respiratory system, circulatory system, autonomous system, central nervous system, somatomotor activity, and behavioral patterns were also recorded. Attention was given to observe the salivation, tremors, diarrhea, lethargy, convulsions, sleep, and coma. The presence or absence of compound-related death of the animals dosed at the first step was to determine the next step. Any mortality during the experiment for 14 days was observed and recorded.
Statistical Analysis: Data are presented as mean ± SEM. One-way ANOVA using Tukey’s employed for post hoc test for multiple comparisons. The value of P<0.05 was considered statistically significant.
RESULTS:
TABLE 1: EFFECT OF EESZ ON ACETYLCHOLINE ESTERASE IN ALUMINIUM CHLORIDE INDUCED RATS
Groups
|
AChE activity (μmoles of substrate hydrolyzed / min / g tissue) | |||
Hippocampus | Cortex | |||
7th day | 14th day | 7th day | 14th day | |
I | 1.58±0.15 a,2 | 2.25±0.21 a,2 | 1.75±0.21 a,2 | 2.92±0.15 b,2 |
II | 4.08±0.19 b,1 | 4.17±0.26 b,1 | 3.50±0.13 b,1 | 4.85±0.11 c,1 |
III | 3.83±0.11c,1,2 | 3.50±0.18 c,1,2 | 3.25±0.21 c,1,2 | 3.75±0.28 b,1,2 |
IV | 2.28±0.08b,1,2 | 2.75±0.13 b,1,2 | 2.08±0.15 b,1,2 | 2.92±0.11 b,1,2 |
V | 2.00±0.20 c,2 | 2.43±0.25 c,2 | 1.88±0.24 b,2 | 2.70±0.29 c,2 |
Values are expressed for 6 animals as mean ± SEM. Statistical significance tested by one-way ANOVA, followed by Tukey’s test. a – P < 0.05; b – P < 0.01; c – P < 0.001;1 – compared with group II, III, IV; 2 – compared with group I, III, IV, V.
FIG. 1: EFFECT OF EESZ ON ACETYLCHOLINE ESTERASE IN ALUMINIUM CHLORIDE INDUCED RATS
TABLE 2: EFFECT OF EESC ON ACETYLCHOLINE ESTERASE IN ALUMINIUM CHLORIDE INDUCED RATS
Groups
|
AChE activity (μmoles of substrate hydrolyzed / min / g tissue) | |||
Hippocampus | Cortex | |||
7th day | 14th day | 7th day | 14th day | |
I | 1.58±0.15 b,2 | 2.25±0.21 b,2 | 1.75±0.21 b,2 | 2.92±0.15 b,2 |
II | 4.08±0.19 b,1 | 4.17±0.26 c,1 | 3.50±0.13 b,1 | 4.85±0.11 c,1 |
III | 2.42±0.20 c,1,2 | 3.33±0.17 c,1,2 | 2.98±0.24 b,1,2 | 3.75±0.25 c,1,2 |
IV | 1.83±0.17 b,1,2 | 2.33±0.17 b,1,2 | 1.92±0.25 c,1,2 | 2.85±0.21 b,1,2 |
V | 2.00±0.20 c,2 | 2.43±0.25 c,2 | 1.88±0.24 c,2 | 2.70±0.29 b,2 |
Values are expressed for 6 animals as mean ± SEM. Statistical significance tested by one-way ANOVA, followed by Tukey’s test. a – P < 0.05; b – P < 0.01; c – P <0.001; 1 – compared with group II, III, IV; 2 – compared with group I, III, IV, V.
FIG. 2: EFFECT OF EESC ON ACETYLCHOLINE ESTERASE IN ALUMINIUM CHLORIDE INDUCED RATS
DISCUSSION: The plant species of Smilax zeylanica and Smilax china roots were collected and extracted with aqueous, chloroform, pet. ether, ethyl acetate, and ethanol. The acetylcholinesterase inhibition activity was investigated; the results obtained were shown (Table 1, 2 and Fig. 1, 2) that ethanolic extracts have anticholinesterase inhibition activity. AD is a progressive neurodegenerative disorder that initially causes memory loss and decreased cognitive behavior. This Learning and memory are controlled by the central cholinergic system. In the present study, the extracts of EESZ and EESC (150 mg/kg and 300 mg/kg of body weight) administered orally and it shows acetylcholine esterase inhibitor activity. In our study, AlCl3 treated rats were increased acetylcholine esterase activity were observed. And acetylcholine levels decreased after treatment with EESC at both doses in the brain.
CONCLUSION: The present work revealed an increase in AChE enzyme activity after treatment with AlCl3 rats. Hence, it is to adopt an increased AChE activity caused by the deposits of Al in the hippocampus and cortex. Hence, it can be used for further study of Alzheimer’s Disease.
ACKNOWLEDGEMENT: The authors that I would like to thank for the great guidance- Dr. V. K. Kalaichelvan M. Pharm, Ph. D, Associate professor; Dr. V. V. Venkatachalam M. Pharm, Ph. D, Associate professor, Annamalai University. We are also indebted to our Annamalai University for facilitating our mission. And Ms. Tamilponni. R to being a part and cared in my hard situations, friends, and my family for their love.
CONFLICTS OF INTEREST: The authors declare that they have no conflicts of interest.
REFERENCES:
- Vasudevan M and Parle M: Pharmacological actions of Thespesia populnea relevant to Alzheimer’s disease. Phytomedicine 2006; 13: 677-87.
- Brookmeyer R, Johnson E, Ziegler GK and Arrighi HM: Forecasting the global burden of Alzheimer’s disease. Alzheimer’s Dement 2007; 3: 186-91.
- Hardy J and Selkoe DJ: The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2012; 297: 353-56.
- Selkoe DJ and Hardy J: The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Molecular Medicine 2016; 8: 595-08.
- Serrano PA, Frosch MP, Masliah E and Hyman BT: Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 2011; 1: 61-89.
- Jucker M and Walker LC: Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 2013; 501: 45-51.
- Sabarisenthil B, Kalaichelvan VK and Anbiah SV: Extract in cognitive dysfunction against aluminium chloride induced rat model of Alzheimer's disease. International Journal of Pharmacy and Biological Sciences 2018; 8: 529-38.
- Sabarisenthil B, Kalaichelvan VK and Kottaimuthu A: Evaluation of in-vitro antioxidant activity on roots of ethanolic extract of Smilax zeylanica. International Journal of Research in Engineering, IT and Social Sciences 2018; 8: 34-38.
- Gopalasatheeskumar K, Kumar GA, Sengottuvel T, Devan VS and Srividhya V: Quantification of total phenolic and flavonoid content in leaves of Cucumis melovaragrestis using UV- spectrophotometer. Asian Journal of Research in Chemistry 2019; 12(6): 335-37.
- Gopalasatheeskumar K, Ariharasivakumar G and Sengottuvel T: Confirmation of best method for detection of alpha amylase activity of Cucumis melovaragrestis (Wild Musk Melon). Journal of Advance Research in Bio Chemistry and Pharmacy 2019; 2(1): 1-3.
- Boopathi T, Gopalasatheeskumar K, Parthiban S, Sangeetha G, Kokila MT and Manimaran T: Evaluation of antimicrobial activity of Tecomastans and Muntingia calabura. World Journal of Pharmaceutical Research 2017; 6(3): 617-27.
- Gopalasatheeskumar K: Significant role of Soxhlet extraction process in phytochemical research. Mintage Journal of Pharmaceutical & Medical Sciences 2018; 7(1): 43-47.
- Sabarisenthil B, Kalaichelvan VK and Anbiah SV: Evaluation of neuroprotective effect of ethanolic extract of root of Smilax china on aluminium chloride induced Alzheimer's disease in Wistar rats. International Journal of Research in Engineering, IT and Social Sciences 2018; 8: 44-51.
- Sabarisenthil B and Kalaichelvan VK: Ethanolic extract of Smilax china on attenuated behavioural impairments, neurochemical deficts against MPTP Induced Parkinson's disease in rats. International Journal of Pharmacy and Biological Sciences 2018; 8: 690-700.
- George L, Ellman K, Diane C, Valentino AJR and Robert M: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 1961; 7: 88-95.
- Yuvaraja KR, Santhiagu A, Jasemine S and Gopalasatheeskumar K: Antioxidant potential of medicinally important plants Ehretia microphylla, Dipteracanthus patulus and Hydnocarpus laurifolia. International Journal of Biology, Pharmacy and Allied Sciences 2020; 9(2): 195-205.
- Yuvaraja KR, Santhiagu A, Jasemine S and Gopalasatheeskumar K: Hepatoprotective activity of chloroform and ethyl acetate extract of Dipteracanthus patulus against paracetamol induced hepatotoxicity in rats through antioxidant mechanism. Research Journal of Pharmacy and Technology 2020; 13(1): 203-08.
- Sabarisenthil B, Kalaichelvan VK and Kottaimuthu A: Ethanolic root extract of Smilax zeylanica on aluminium chloride induced oxidative stress in wistar rats. Journal of Drug Delivery and Therapeutics 2018; 8(6S): 48-52.
- Sabarisenthil B, Kalaichelvan VK and Kottaimuthu A: HPTLC fingerprinting and GC-MS analysis of phytoconstitutents present in ethanollic extract of roots of Similax zeylanica. European Journal of Biomedical and Parmaceutical Sciences 2018; 5(11): 684-92.
How to cite this article:
Yokeshwaran A, Venkatachalam VV, Sabarisenthil B and Kalaichelvan VK: Anticholinesterase activity of plant extracts of Smilax zeylanica and Smilax china. Int J Pharm Sci & Res 2020; 11(9): 4370-74. doi: 10.13040/IJPSR.0975-8232.11(9).4370-74.
All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
30
4370-4374
649
757
English
IJPSR
A. Yokeshwaran *, V. V. Venkatachalam, B. Sabarisenthil and V. K. Kalaichelvan
Department of Pharmacy, FEAT, Annamalai University, Annamalai Nagar, Chidambaram, Tamil Nadu, India.
madanamyogi@gmail.com
22 September 2019
26 March 2020
28 March 2020
10.13040/IJPSR.0975-8232.11(9).4370-74
01 September 2020